Jeffrey G. Lamothe - Aug 9, 2022 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
CFO
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Stock symbol
APVO
Transactions as of
Aug 9, 2022
Transactions value $
$0
Form type
4
Date filed
8/10/2022, 04:08 PM
Previous filing
Jun 7, 2022
Next filing
Jan 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Award $0 +5.5K $0.00 5.5K Aug 9, 2022 Common Stock 5.5K Direct F1, F2
transaction APVO Stock Option (right to buy) Award $0 +5.5K $0.00 5.5K Aug 9, 2022 Common Stock 5.5K $4.32 Direct F3
transaction APVO Restricted Stock Unit Award $0 +24K $0.00 24K Aug 9, 2022 Common Stock 24K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 The RSUs vest in three approximately equal annual installments beginning on August 8, 2023.
F3 The option vests in three approximately equal annual installments beginning on August 8, 2023.
F4 The RSUs vest in two approximately equal annual installments beginning on August 8, 2023.